Guwahati: Institute of Advanced Study in Science and Technology (IASST), Guwahati on Thursday signed a crucial R&D collaboration agreement with Bharat Biotech International Ltd (BBIL), Hyderabad.
This collaboration aims to bring to market innovative health products developed from probiotics isolated from traditional fermented foods of Northeast India.
IASST director Prof Ashis Mukherjee highlighted the importance of this collaboration, noting that it provides a unique opportunity to convert academic research into commercially viable products. Bharat Biotech, a global leader in vaccine and health solutions, will be crucial in conducting pre-clinical and clinical trials to ensure these probiotics meet regulatory standards.
The agreement delineates each party’s obligations, with IASST contributing its scientific understanding and spearheading the research and Bharat Biotech and Probiomics Private Limited participating in the commercialisation process.
A monitoring committee, comprising representatives from all stakeholders, will supervise the project’s advancement.
The agreement specifies that IASST will get royalties from the sale of items generated via this partnership.
“This collaboration marks a significant milestone for IASST as it aligns with the broader vision of promoting the bioeconomy of the northeast by utilising its rich biodiversity. The probiotic products, rooted in traditional knowledge, are expected to provide natural solutions for lifestyle diseases like diabetes and obesity,” a spokesperson said.